MASTER CLINICAL DEVELOPMENT AGREEMENT betweenMaster Clinical Development Agreement • May 13th, 2005 • Avanir Pharmaceuticals • Pharmaceutical preparations • Pennsylvania
MASTER CLINICAL DEVELOPMENT AGREEMENT between NEUROBIOLOGICAL TECHNOLOGIES, INC. Mahwah, NJ 07495 and SCIREX CORPORATION Horsham, PA 19044Master Clinical Development Agreement • September 28th, 2005 • Neurobiological Technologies Inc /Ca/ • Biological products, (no disgnostic substances) • California
THIS MASTER CLINICAL DEVELOPMENT AGREEMENT (“Agreement”), made as of the date last signed below is by and between Neurobiological Technologies, Inc., a company having its principal place of business at Crossroads Corporate Center, One International Boulevard, Suite 400, Mahwah, NJ 07495 (“NTI”), and SCIREX Corporation, a corporation of the State of Delaware having its principal place of business at 755 Business Center Drive, Horsham, PA 19044 (“SCIREX”).
MASTER CLINICAL DEVELOPMENT AGREEMENT between BIODELIVERY SCIENCES INTERNATIONAL Raleigh, NC 27607 and PREMIER RESEARCH INTERNATIONAL LLC Philadelphia, PA 19102Master Clinical Development Agreement • May 15th, 2009 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Pennsylvania
THIS AGREEMENT, made as of the date last signed below is by and between BioDelivery Sciences International, a company having its principal place of business at 801 Corporate Center Drive, Suite 210, Raleigh, NC 27607 (“BDSI”), and Premier Research International LLC, a corporation having a place of business at Centre Square West, 1500 Market Street, Suite 3500W, Philadelphia, PA 19102 (“Premier Research”).
